🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Kidney Transplant Recipients

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant NCT07508787Phase 214 sites📍 Sacramento📍 Tampa📍 Atlanta Nefro Avillion Clinical Development, LLC · Tests: Siplizumab, Rabbit anti-thymocyte globulin Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus NCT06701825Phase 41 site📍 Madrid Instituto de Investigación Hospital Universitario La Paz · Tests: Tacrolimus, Tacrolimus Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft NCT04989491Phase 41 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Rituximab, control group Double Voiding and Post-transplant UTI NCT05711446NA1 site📍 New York Weill Medical College of Cornell University · Tests: Double Voiding, Regular Voiding Vascular Complications After Kidney Transplantation NCT07531966n/a3 sites📍 Aarhus📍 Copenhagen📍 Odense University of Aarhus · Tests: Catheter-based angiography, Measurement of translesional pressure gradients, Intravascular ultrasound (IVUS), Percutane… Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine NCT07600541n/a2 sites📍 Paris📍 Paris Paris Translational Research Center for Organ Transplantati… A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077) NCT07199465Phase 121 sites📍 Birmingham📍 Los Angeles📍 Los Angeles Merck Sharp & Dohme LLC · Tests: Letermovir The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study NCT06059664Phase 21 site📍 Chapel Hill University of North Carolina, Chapel Hill · Tests: Finerenone Oral Tablet, Placebo Defibrotide Dose-escalation for SOS Post-HSCT NCT05987124Phase 21 site📍 Vallhala New York Medical College · Tests: Defibrotide Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure NCT06881927Phase 41 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: Hydrocortisone Hemisuccinate: 200 mg per day., reduction of the level of immunosuppression Daratumumab for Late Antibody-Mediated Rejection NCT07081126NA1 site📍 Martin University Hospital, Martin · Tests: Daratumumab (Subcutaneously), control group Muscle Oxygenation, Functional Capacity and Frailty in Kidney Transplant Recipients with and Without Inspiratory Muscle Weakness NCT06706492n/a1 site📍 Ankara Hacettepe University Exercise and Diet Effects in Reducing Cardiovascular Risk in Kidney Transplant Recipients NCT06806670NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: lifestyle intervention Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) NCT06341543NA1 site📍 Grenoble University Hospital, Grenoble · Tests: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes)., Communication of the result of the … Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients NCT06407232Phase 31 site📍 Madison University of Wisconsin, Madison · Tests: Letermovir Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors NCT07368153Phase 24 sites📍 Bern📍 Zurich📍 Lausanne University Hospital, Basel, Switzerland · Tests: indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, placebo Tirzepatide (Spartina) in Obese Kidney Transplant Recipients NCT07423247Phase 41 site📍 Tehran Shahid Beheshti University of Medical Sciences · Tests: Tirzepatide Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study NCT07045467Phase 11 site📍 Jinan Qianfoshan Hospital · Tests: Remimazolam Besylate A Multicenter Randomized Controlled Trial to Treat Acute T Cell Mediated Rejection in Kidney and Kidney-Pancreas Transplant Recipients NCT06474273Phase 330 sites📍 Lambton📍 Randwick📍 Westmead University of Sydney · Tests: Methylprednisolone, Prednisone Randomized Trial of SGLT2i in Heart Transplant Recipients NCT06625073Phase 46 sites📍 Palo Alto📍 Nashville📍 Houston VA Office of Research and Development · Tests: Empagliflozin, Placebo Use of CGM in Kidney Transplant Recipients NCT04783441NA1 site📍 Sacramento University of California, Davis · Tests: Dexcom G6, Dexcom G6 blinded sensor Pilot Trial of Supplemental Vitamin A and Nicotinamide NCT05702398EARLY Phase 11 site📍 Providence Rhode Island Hospital · Tests: Vitamin A, Nicotinamide, Other: Placebo A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population NCT07006831n/a6 sites📍 San Diego📍 San Francisco📍 Atlanta Devyser Inc. Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study NCT07294547NA1 site📍 Taipei National Taiwan University Hospital · Tests: Valacyclovir (Valtrex), Valganciclovir (Valcyte) Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients NCT06798909Phase 38 sites📍 San Francisco📍 Miami📍 Atlanta University of California, San Francisco · Tests: Valganciclovir (Pre-emptive CMV Therapy), Valganciclovir CMV Prophylaxis Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients NCT06409819Phase 1, Phase 21 site📍 La Jolla University of California, San Diego · Tests: phage therapy, control Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients NCT01531257n/a1 site📍 Chicago Northwestern University A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients NCT05325008Phase 313 sites📍 Canberra📍 New Lambton Heights📍 Randwick The University of Queensland · Tests: Immunosuppression reduction/modification + intravenous immunoglobulin, Immunosuppression reduction/modification Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial. NCT05597540Phase 39 sites📍 Bordeaux📍 Boulogne-Billancourt📍 Créteil Assistance Publique - Hôpitaux de Paris · Tests: Short antibiotic treatment, Usual antibiotic treatment Structured Program of Exercise for Recipients of Kidney Transplantation NCT04954690NA1 site📍 San Francisco University of California, San Francisco · Tests: Structured Program of exercise for Recipients of Kidney Transplantation (WC), Structured Program of exercise for Recipi…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy